A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Clinical trial NCT07018323 · RECRUITING
Trial details
- NCT number
- NCT07018323
- Sponsor
- Immunovant Sciences GmbH
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-19
- Primary completion
- 2027-05-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.